This work brings together knowledge about the pain of herpes zoster and postherpetic neuralgia. The volume aims to expand knowledge not only of this specialized syndrome, but of every kind of chronic pain. It deals with all the basic scientific information on the acute and chronic stages of herpes zoster, as well as knowledge of all the possible treatments for this terrible affliction. A variety of treatment modalities are described, and more people are now obtaining relief than was thought possible a decade ago. research, leading to a more thorough understanding of the problems and to pain relief for those who continue to suffer.
Representing a state-of-the-art appraisal of this viral infection and its complications, this book comprises contributions from international authorities in infectious diseases, varicella-voster virus infections, and neuropathic pain. Important new information is presented on the role of the virus in terms of vascular risk, notably in heart attack, stroke and granulomatous angiitis (temporal arteritis). Similarly, new information on gastrointestinal involvement, often in the absence of rash and as seen with vasculopathies, is covered. The reader will benefit from new research into the pathology, pathophysiology and treatment of postherpetic neuralgia and its complications, and special attention is paid to prevention through zoster vaccination using the current zoster vaccine, and a novel, broader option that can be used in immunocompromised patients. This book follows the two editions of the book, Herpes Zoster and Postherpetic Neuralgia, and is divided into sections for the convenience of the reader. A section on herpes zoster includes epidemiology and natural history of the varicella zoster virus, herpes zoster ophthalmicus, neurological complications, the role of varicella zoster virus in giant cell arteritis, concern about increased vascular risk of heart attack and stroke, antiviral therapy, and treatment of skin manifestations. A section on postherpetic neuralgia includes important information on the effect of herpes zoster and postherpetic neuralgia on quality of life, the neuropathology and pathophysiological mechanisms in postherpetic neuralgia, and the new concept of persistent ganglionitis as the cause of postherpetic neuralgia. A comparison is made between facial postherpetic neuralgia and trigeminal neuralgia. There is an extensive section on treatment, including the role of opioids, the general treatment of postherpetic neuralgia, intervention and neurosurgical approaches, and covering guidelines for clinical trial designs in postherpetic neuralgia. A final section addresses the questions of whether aggressive treatment of acute herpes zoster can prevent postherpetic neuralgia and includes a critically important chapter on herpes zoster vaccines.
This comprehensive account of the human herpesviruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein–Barr virus, Kaposi's Sarcoma-associated herpesvirus, cytomegalovirus, HHV6A, 6B and 7, and varicella-zoster virus. The viral diseases and cancers they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology of infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth, both scientifically and in terms of clinical guidelines for patient care. The text is illustrated generously throughout and is fully referenced to the latest research and developments.
Pain Management: A Problem-Based Learning Approach combines comprehensive didactics on pain management topics with board like questions grouped in real-time pain practice exams. It is uniquely designed to maximize the retaining of learned information by the long-life learner in the ABA certification/recertification process. It is also ideally used as a reference compendium offering theoretical and practical advice to the busy pain practitioner.
Herpes zoster (shingles) is a serious neurocutaneous disease caused by a reactivation of latent varicella-zoster virus (VZV). It has been underestimated in terms of its burden, particularly in the elderly population and in immunocompromised patients, who
Edited by internationally recognized pain experts, this book offers 73 clinically relevant cases, accompanied by discussion in a question-and-answer format.
Herpes zoster, better known as shingles, affects up to twenty percent of the population of the United States. Caused by the same virus that causes chicken pox, shingles affects adults who have had chicken pox and who suffer from a weakened immune system. The authors cite the latest research on Shingles and its prevention and provide tips on early recognition of shingles as well as descriptions of commonly used treatments for shingles.
Postherpetic neuralgia is diagnosed when pain is still present three months after the resolution of the herpes zoster. The virus is known to reactivate in certain states of the body. There are ways to manage pain. -Complications of shingles -Treatment of postherpetic neuralgia -Treatment for pain -Prognosis after treatment
Characterized by clarity and straddling the line between scope and depth of information, this concise book provides physicians a comprehensive overview of pain medicine. Chapters are written by some of the leading minds in pain medicine and feature case studies, key points and suggested readings. Multidisciplinary approaches to the clinical and financial challenges of pain with the goal of improving patient quality of life are also discussed. Additionally, the book is in is in tight alignment with the information that trainees are expected to master for the American Board of Anesthesiology’s pain medicine subspecialty certification, as outlined by the Joint Council on Anesthesiology Examinations; it covers the diagnosis of pain states, the management of pain, acute pain, radicular pain, neuropathic pain, chronic visceral pain, headaches, and special populations. This book is a must-have for anyone new to pain medicine or studying for the subspecialty certification.
In 1900, for every 1,000 babies born in the United States, 100 would die before their first birthday, often due to infectious diseases. Today, vaccines exist for many viral and bacterial diseases. The National Childhood Vaccine Injury Act, passed in 1986, was intended to bolster vaccine research and development through the federal coordination of vaccine initiatives and to provide relief to vaccine manufacturers facing financial burdens. The legislation also intended to address concerns about the safety of vaccines by instituting a compensation program, setting up a passive surveillance system for vaccine adverse events, and by providing information to consumers. A key component of the legislation required the U.S. Department of Health and Human Services to collaborate with the Institute of Medicine to assess concerns about the safety of vaccines and potential adverse events, especially in children. Adverse Effects of Vaccines reviews the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the National Vaccine Injury Compensation Program (VICP), including the varicella zoster vaccine, influenza vaccines, the hepatitis B vaccine, and the human papillomavirus vaccine, among others. For each possible adverse event, the report reviews peer-reviewed primary studies, summarizes their findings, and evaluates the epidemiological, clinical, and biological evidence. It finds that while no vaccine is 100 percent safe, very few adverse events are shown to be caused by vaccines. In addition, the evidence shows that vaccines do not cause several conditions. For example, the MMR vaccine is not associated with autism or childhood diabetes. Also, the DTaP vaccine is not associated with diabetes and the influenza vaccine given as a shot does not exacerbate asthma. Adverse Effects of Vaccines will be of special interest to the National Vaccine Program Office, the VICP, the Centers for Disease Control and Prevention, vaccine safety researchers and manufacturers, parents, caregivers, and health professionals in the private and public sectors.
